| 1 |
Yu X, Shao K, Wan K, Li T, Li Y, Zhu X, Han Y. Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease. Chin Med J (Engl) 2023. [PMID: 36914945 DOI: 10.1097/CM9.0000000000002566] [Reference Citation Analysis]
|
| 2 |
Simões JLB, Sobierai LD, Leal IF, Dos Santos MVR, Coiado JV, Bagatini MD. Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer's Disease in the Context of the COVID-19 Pandemic. Neuroscience 2023;512:110-32. [PMID: 36526078 DOI: 10.1016/j.neuroscience.2022.12.007] [Reference Citation Analysis]
|
| 3 |
Zhang C, Talifu Z, Xu X, Liu W, Ke H, Pan Y, Li Y, Bai F, Jing Y, Li Z, Li Z, Yang D, Gao F, Du L, Li J, Yu Y. MicroRNAs in spinal cord injury: A narrative review. Front Mol Neurosci 2023;16:1099256. [PMID: 36818651 DOI: 10.3389/fnmol.2023.1099256] [Reference Citation Analysis]
|
| 4 |
Takousis P, Devonshire AS, Redshaw N, von Baumgarten L, Whale AS, Jones GM, Fernandez-Gonzalez A, Martin J, Foy CA, Alexopoulos P, Huggett JF, Perneczky R. A standardised methodology for the extraction and quantification of cell-free DNA in cerebrospinal fluid and application to evaluation of Alzheimer's disease and brain cancers. N Biotechnol 2022;72:97-106. [PMID: 36202346 DOI: 10.1016/j.nbt.2022.10.001] [Reference Citation Analysis]
|
| 5 |
Abuelezz NZ, Nasr FE, Abdel Aal WM, Molokhia T, Zaky A. Sera miR-34a, miR-29b and miR-181c as potential novel diagnostic biomarker panel for Alzheimers in the Egyptian population. Exp Gerontol 2022;169:111961. [PMID: 36155067 DOI: 10.1016/j.exger.2022.111961] [Reference Citation Analysis]
|
| 6 |
Dobricic V, Schilling M, Farkas I, Gveric DO, Ohlei O, Schulz J, Middleton L, Gentleman SM, Parkkinen L, Bertram L, Lill CM. Common signatures of differential microRNA expression in Parkinson's and Alzheimer's disease brains. Brain Commun 2022;4:fcac274. [PMID: 36382223 DOI: 10.1093/braincomms/fcac274] [Reference Citation Analysis]
|
| 7 |
Migliore L, Coppedè F. Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics. Nat Rev Neurol 2022. [PMID: 36180553 DOI: 10.1038/s41582-022-00714-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Wang Y, Lv S, Zhou X, Niu X, Chen L, Yang Z, Peng D. Identification of hsa-miR-365b-5p's role in Alzheimer's disease: a combined analysis of miRNA and mRNA microarrays. Neurosci Lett 2022;:136892. [PMID: 36181964 DOI: 10.1016/j.neulet.2022.136892] [Reference Citation Analysis]
|
| 9 |
Wen Q, Verheijen M, Wittens MMJ, Czuryło J, Engelborghs S, Hauser D, van Herwijnen MHM, Lundh T, Bergdahl IA, Kyrtopoulos SA, de Kok TM, Smeets HJM, Briedé JJ, Krauskopf J. Lead-exposure associated miRNAs in humans and Alzheimer’s disease as potential biomarkers of the disease and disease processes. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-20305-5] [Reference Citation Analysis]
|
| 10 |
Tang Q, Zou R, Lei X, Tan S, Wang J. Polymer nanoparticle delivery of microRNA-1303 suppresses renal cell carcinoma differentiation via regulation of small nucleolar RNA host gene 16. mat express 2022;12:1147-1154. [DOI: 10.1166/mex.2022.2257] [Reference Citation Analysis]
|
| 11 |
Dobricic V, Schilling M, Schulz J, Zhu LS, Zhou CW, Fuß J, Franzenburg S, Zhu LQ, Parkkinen L, Lill CM, Bertram L. Differential microRNA expression analyses across two brain regions in Alzheimer's disease. Transl Psychiatry 2022;12:352. [PMID: 36038535 DOI: 10.1038/s41398-022-02108-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Yaqub A, Mens MMJ, Klap JM, Weverling GJ, Klatser P, Brakenhoff JPJ, Roshchupkin GV, Ikram MK, Ghanbari M, Ikram MA. Genome-wide profiling of circulatory microRNAs associated with cognition and dementia. Alzheimers Dement 2022. [PMID: 35946915 DOI: 10.1002/alz.12752] [Reference Citation Analysis]
|
| 13 |
Henriques DG, Lamback EB, Dezonne RS, Kasuki L, Gadelha MR. MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor Ligands. Int J Mol Sci 2022;23. [PMID: 35955787 DOI: 10.3390/ijms23158653] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Shafiei B, Shabani M, Afgar A, Rajizadeh MA, Nazari-Robati M. Trehalose Attenuates Learning and Memory Impairments in Aged Rats via Overexpression of miR-181c. Neurochem Res 2022. [PMID: 35906351 DOI: 10.1007/s11064-022-03687-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Faldu KG, Shah JS. Alzheimer's disease: a scoping review of biomarker research and development for effective disease diagnosis. Expert Rev Mol Diagn 2022. [PMID: 35855631 DOI: 10.1080/14737159.2022.2104639] [Reference Citation Analysis]
|
| 16 |
Zhang W, Wei H, Liu B. idenMD-NRF: a ranking framework for miRNA-disease association identification. Brief Bioinform 2022;23:bbac224. [PMID: 35679537 DOI: 10.1093/bib/bbac224] [Reference Citation Analysis]
|
| 17 |
Xia P, Chen J, Liu Y, Cui X, Wang C, Zong S, Wang L, Lu Z. MicroRNA-22-3p ameliorates Alzheimer's disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus. J Neuroinflammation 2022;19:180. [PMID: 35821145 DOI: 10.1186/s12974-022-02548-1] [Reference Citation Analysis]
|
| 18 |
Sadlon A, Takousis P, Evangelou E, Prokopenko I, Alexopoulos P, Udeh-momoh CT, Price G, Middleton L, Perneczky R, the Alzheimer’s Disease Neuroimaging Initiative. A multi-omics approach identifies a blood-based miRNA signature of cognitive decline in two large observational trials.. [DOI: 10.1101/2022.06.17.22276532] [Reference Citation Analysis]
|
| 19 |
Noronha O, Mesarosovo L, Anink JJ, Iyer A, Aronica E, Mills JD. Differentially Expressed miRNAs in Age-Related Neurodegenerative Diseases: A Meta-Analysis. Genes (Basel) 2022;13:1034. [PMID: 35741796 DOI: 10.3390/genes13061034] [Reference Citation Analysis]
|
| 20 |
Banack SA, Stark AC, Cox PA. A possible blood plasma biomarker for early-stage Alzheimer's disease. PLoS One 2022;17:e0267407. [PMID: 35446894 DOI: 10.1371/journal.pone.0267407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Chauhan H, Gupta P, Saxena B. MicroRNAs as Future Treatment Tools and Diagnostic Biomarkers in Alzheimer’s Disease. Alzheimer's Disease [Working Title] 2022. [DOI: 10.5772/intechopen.103173] [Reference Citation Analysis]
|
| 22 |
Varesi A, Carrara A, Pires VG, Floris V, Pierella E, Savioli G, Prasad S, Esposito C, Ricevuti G, Chirumbolo S, Pascale A. Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview. Cells 2022;11:1367. [PMID: 35456047 DOI: 10.3390/cells11081367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 23 |
Mankhong S, Kim S, Lee S, Kwak H, Park D, Joa K, Kang J. Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers. Biomedicines 2022;10:850. [DOI: 10.3390/biomedicines10040850] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 24 |
Liu S, Fan M, Zheng Q, Hao S, Yang L, Xia Q, Qi C, Ge J. MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets. Biomed Pharmacother 2022;148:112681. [PMID: 35177290 DOI: 10.1016/j.biopha.2022.112681] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 25 |
Liu H, Li T, Dong C, Lyu J. Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma. PLoS ONE 2022;17:e0264645. [DOI: 10.1371/journal.pone.0264645] [Reference Citation Analysis]
|
| 26 |
Zeng L, Jiang H, Ashraf GM, Liu J, Wang L, Zhao K, Liu M, Li Z, Liu R. Implications of miR-148a-3p/p35/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt/CREB in Alzheimer's disease. Mol Ther Nucleic Acids 2022;27:256-75. [PMID: 35024240 DOI: 10.1016/j.omtn.2021.11.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 27 |
Guévremont D, Tsui H, Knight R, Fowler CJ, Masters CL, Martins RN, Abraham WC, Tate WP, Cutfield NJ, Williams JM. Plasma microRNA vary in association with the progression of Alzheimer's disease. Alzheimers Dement (Amst) 2022;14:e12251. [PMID: 35141392 DOI: 10.1002/dad2.12251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, Liu R, Feng J, Wang X. Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention. Ageing Res Rev 2022;74:101544. [PMID: 34933129 DOI: 10.1016/j.arr.2021.101544] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 29 |
Dobricic V, Schilling M, Farkas I, Gveric DO, Schulz J, Middleton L, Gentleman S, Parkkinen L, Bertram L, Lill CM. Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains.. [DOI: 10.1101/2022.01.31.478486] [Reference Citation Analysis]
|
| 30 |
Bai X, Bian Z. MicroRNA-21 Is a Versatile Regulator and Potential Treatment Target in Central Nervous System Disorders. Front Mol Neurosci 2022;15:842288. [DOI: 10.3389/fnmol.2022.842288] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 31 |
Iulita MF, Granholm A, Carmona-iragui M, Hamlett ED, Fortea J, Ledreux A. Fluid biomarkers for Alzheimer's disease in Down syndrome: Current status and novel trends. The Neurobiology of Aging and Alzheimer Disease in Down Syndrome 2022. [DOI: 10.1016/b978-0-12-818845-3.00010-4] [Reference Citation Analysis]
|
| 32 |
Grimm SL, Mendez EF, Stertz L, Meyer TD, Fries GR, Gandhi T, Kanchi R, Selvaraj S, Teixeira AL, Kosten TR, Gunaratne P, Coarfa C, Walss-Bass C. MicroRNA-mRNA networks are dysregulated in opioid use disorder postmortem brain: Further evidence for opioid-induced neurovascular alterations. Front Psychiatry 2022;13:1025346. [PMID: 36713930 DOI: 10.3389/fpsyt.2022.1025346] [Reference Citation Analysis]
|
| 33 |
Li H, Liu Q, Zhang Q, Xue X, Zhang J, Zhang J, Lin L, Niu Q. miR-200a-3p Regulates PRKACB and Participates in Aluminium-Induced Tau Phosphorylation in PC12 Cells. Neurotox Res 2022;40:1963-78. [PMID: 36459375 DOI: 10.1007/s12640-022-00609-0] [Reference Citation Analysis]
|
| 34 |
Yuen SC, Lee SM, Leung SW. Putative Factors Interfering Cell Cycle Re-Entry in Alzheimer's Disease: An Omics Study with Differential Expression Meta-Analytics and Co-Expression Profiling. J Alzheimers Dis 2021. [PMID: 34924393 DOI: 10.3233/JAD-215349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 35 |
Peña-Bautista C, Álvarez-Sánchez L, Cañada-Martínez AJ, Baquero M, Cháfer-Pericás C. Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages. Biomedicines 2021;9:1812. [PMID: 34944628 DOI: 10.3390/biomedicines9121812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Jia L, Zhu M, Yang J, Pang Y, Wang Q, Li Y, Li T, Li F, Wang Q, Li Y, Wei Y. Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer's disease. BMC Med 2021;19:264. [PMID: 34775974 DOI: 10.1186/s12916-021-02142-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 37 |
Walgrave H, Zhou L, De Strooper B, Salta E. The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives. Mol Neurodegener 2021;16:76. [PMID: 34742333 DOI: 10.1186/s13024-021-00496-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 38 |
Chen D, Yu W, Aitken L, Gunn-Moore F. Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer's Disease. Cells 2021;10:3024. [PMID: 34831245 DOI: 10.3390/cells10113024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 39 |
Lauretti E, Dabrowski K, Praticò D. The neurobiology of non-coding RNAs and Alzheimer's disease pathogenesis: Pathways, mechanisms and translational opportunities. Ageing Res Rev 2021;71:101425. [PMID: 34384901 DOI: 10.1016/j.arr.2021.101425] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 40 |
Kim SH, Choi KY, Park Y, McLean C, Park J, Lee JH, Lee KH, Kim BC, Huh YH, Lee KH, Song WK. Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer's Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes. Cells 2021;10:2697. [PMID: 34685681 DOI: 10.3390/cells10102697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 41 |
Lusardi TA, Sandau US, Sakhanenko NA, Baker SCB, Wiedrick JT, Lapidus JA, Raskind MA, Li G, Peskind ER, Galas DJ, Quinn JF, Saugstad JA. Cerebrospinal Fluid MicroRNA Changes in Cognitively Normal Veterans With a History of Deployment-Associated Mild Traumatic Brain Injury. Front Neurosci 2021;15:720778. [PMID: 34580583 DOI: 10.3389/fnins.2021.720778] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Vogrinc D, Goričar K, Kunej T, Dolžan V. Systematic Search for Novel Circulating Biomarkers Associated with Extracellular Vesicles in Alzheimer's Disease: Combining Literature Screening and Database Mining Approaches. J Pers Med 2021;11:946. [PMID: 34683087 DOI: 10.3390/jpm11100946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 43 |
Dakterzada F, David Benítez I, Targa A, Lladó A, Torres G, Romero L, de Gonzalo-Calvo D, Moncusí-Moix A, Tort-Merino A, Huerto R, Sánchez-de-la-Torre M, Barbé F, Piñol-Ripoll G. Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer's Disease. Front Aging Neurosci 2021;13:705989. [PMID: 34497505 DOI: 10.3389/fnagi.2021.705989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 44 |
Zhang X, Wang Y, Liu W, Wang T, Wang L, Hao L, Ju M, Xiao R. Diet quality, gut microbiota, and microRNAs associated with mild cognitive impairment in middle-aged and elderly Chinese population. Am J Clin Nutr 2021;114:429-40. [PMID: 33871591 DOI: 10.1093/ajcn/nqab078] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 45 |
Su Z, Ren N, Ling Z, Sheng L, Zhou S, Guo C, Ke Z, Xu T, Qin Z. Differential expression of microRNAs associated with neurodegenerative diseases and diabetic nephropathy in protein l-isoaspartyl methyltransferase-deficient mice. Cell Biol Int 2021. [PMID: 34314072 DOI: 10.1002/cbin.11679] [Reference Citation Analysis]
|
| 46 |
Yuen SC, Liang X, Zhu H, Jia Y, Leung SW. Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer's disease by meta-analysis and adaptive boosting ensemble learning. Alzheimers Res Ther 2021;13:126. [PMID: 34243793 DOI: 10.1186/s13195-021-00862-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 47 |
Dobricic V, Schilling M, Schulz J, Zhu L, Zhou C, Fuß J, Franzenburg S, Zhu L, Parkkinen L, Lill CM, Bertram L. Differential microRNA expression analyses across two brain regions in Alzheimer’s disease.. [DOI: 10.1101/2021.05.31.446406] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 48 |
Zhao X, Kang J, Svetnik V, Warden D, Wilcock G, David Smith A, Savage MJ, Laterza OF. A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer Disease. J Appl Lab Med 2020;5:15-28. [PMID: 31811079 DOI: 10.1373/jalm.2019.029595] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 49 |
Vastrad B, Vastrad C. Identification of Key Pathways and Genes in Dementia via Integrated Bioinformatics Analysis.. [DOI: 10.1101/2021.04.18.440371] [Reference Citation Analysis]
|
| 50 |
Nagaraj S, Want A, Laskowska-Kaszub K, Fesiuk A, Vaz S, Logarinho E, Wojda U. Candidate Alzheimer's Disease Biomarker miR-483-5p Lowers TAU Phosphorylation by Direct ERK1/2 Repression. Int J Mol Sci 2021;22:3653. [PMID: 33915734 DOI: 10.3390/ijms22073653] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 51 |
Li QS, Cai D. Integrated miRNA-Seq and mRNA-Seq Study to Identify miRNAs Associated With Alzheimer's Disease Using Post-mortem Brain Tissue Samples. Front Neurosci 2021;15:620899. [PMID: 33833661 DOI: 10.3389/fnins.2021.620899] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 52 |
Vogrinc D, Goričar K, Dolžan V. Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review. Front Aging Neurosci 2021;13:646901. [PMID: 33815092 DOI: 10.3389/fnagi.2021.646901] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 53 |
Su W, Bi X, Wang Y, Baudry M. Changes in neurodegeneration-related miRNAs in brains from CAPN1-/- mice. BBA Adv 2021;1:100004. [PMID: 34286311 DOI: 10.1016/j.bbadva.2021.100004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 54 |
Dakterzada F, Targa A, Benítez ID, Romero-ElKhayat L, de Gonzalo-Calvo D, Torres G, Moncusí-Moix A, Huerto R, Sánchez-de-la-Torre M, Barbé F, Piñol-Ripoll G. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease. Alzheimers Res Ther 2020;12:163. [PMID: 33278902 DOI: 10.1186/s13195-020-00735-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 55 |
Forloni G. Alzheimer's disease: from basic science to precision medicine approach. BMJ Neurol Open 2020;2:e000079. [PMID: 33681801 DOI: 10.1136/bmjno-2020-000079] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 56 |
Navas-Carrillo D, Rivera-Caravaca JM, Sampedro-Andrada A, Orenes-Piñero E. Novel biomarkers in Alzheimer's disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites. Crit Rev Clin Lab Sci 2021;58:167-79. [PMID: 33137264 DOI: 10.1080/10408363.2020.1833298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 57 |
Wei W, Wang ZY, Ma LN, Zhang TT, Cao Y, Li H. MicroRNAs in Alzheimer's Disease: Function and Potential Applications as Diagnostic Biomarkers. Front Mol Neurosci 2020;13:160. [PMID: 32973449 DOI: 10.3389/fnmol.2020.00160] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 58 |
Soares Martins T, Trindade D, Vaz M, Campelo I, Almeida M, Trigo G, da Cruz E Silva OAB, Henriques AG. Diagnostic and therapeutic potential of exosomes in Alzheimer's disease. J Neurochem 2021;156:162-81. [PMID: 32618370 DOI: 10.1111/jnc.15112] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 59 |
Reiss AB, Glass AD, Wisniewski T, Wolozin B, Gomolin IH, Pinkhasov A, De Leon J, Stecker MM. Alzheimer's disease: many failed trials, so where do we go from here? J Investig Med 2020;68:1135-40. [PMID: 32699179 DOI: 10.1136/jim-2020-001297] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 60 |
Improta-Caria AC, Nonaka CKV, Cavalcante BRR, De Sousa RAL, Aras Júnior R, Souza BSF. Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease. Int J Mol Sci 2020;21:E4977. [PMID: 32674523 DOI: 10.3390/ijms21144977] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 61 |
Yoshiko Y, Minamizaki T. Emerging roles of microRNAs as extracellular vesicle cargo secreted from osteoblasts. J Oral Biosci 2020;62:228-34. [PMID: 32535286 DOI: 10.1016/j.job.2020.05.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 62 |
Indrieri A, Carrella S, Carotenuto P, Banfi S, Franco B. The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer. Int J Mol Sci 2020;21:E2092. [PMID: 32197476 DOI: 10.3390/ijms21062092] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 17.3] [Reference Citation Analysis]
|
| 63 |
Wang X, Li X, Huang B, Yang L, Chen K, Zhao D, Luo X, Wang Y. Downregulation of miR-33 Has Protective Effect Against Aβ₂₅₋₃₅-Induced Injury in SH-SH-SY5Y Cells. Med Sci Monit 2020;26:e921026. [PMID: 32119650 DOI: 10.12659/MSM.921026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 64 |
Pathak GA, Zhou Z, Silzer TK, Barber RC, Phillips NR; Alzheimer's Disease Neuroimaging Initiative, Breast and Prostate Cancer Cohort Consortium, and Alzheimer's Disease Genetics Consortium. Two-stage Bayesian GWAS of 9576 individuals identifies SNP regions that are targeted by miRNAs inversely expressed in Alzheimer's and cancer. Alzheimers Dement 2020;16:162-77. [PMID: 31914222 DOI: 10.1002/alz.12003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
